Dopamine Hci Injection, Solution, Concentrate
Product Images NDC 51662-1291

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Dopamine Hci (NDC 51662-1291). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Vial Label (1007700 0409 5820 01 Dopamine Vial)

This is a description of a 5 mL single-dose container of Dopamine HCI USP which contains sodium metabisulfite as a stabilizer. It also contains Citric acid, anhyd. and sodium Brony citrate, dinyd. which are added as buffers. It must be diluted before use. The product is manufactured by Hospira, Inc. in Lake Forest, Illinois, USA.*

FDA Label Image

Structure (Desc Structure)

FDA Label Image

Dosage 1 (Dosage And Admin)

This document provides information about the concentration of Dopamine Hydrochloride Injection, USP available in 40 mg/mL and 80 mg/mL. The volume offered is 10mL in a 250 mL bottle of LV. solution with strengths varying from 800 to 3200 meg/mL, 10mL in a 250 mL bottle of LV. solution with strengths varying from 400 to 1600 meg/mL and 10mL in a 1000 mL bottle of LV. solution with strengths varying from 200 to 800 meg/mL.*

FDA Label Image

Logo (How Supplied Logo)

FDA Label Image

How Supplied 1 (How Supplied)

This is a unit of sale description for pharmaceutical products. The first product has an NDC code of 0409-5820-01, comes in a carton of 25 and has a total volume of 5mL with a concentration of 200mg/5mL (40mg/mL). The second product has an NDC code of 0409-9104-20, comes in a carton of 25 and has a total volume of 10mL with a concentration of 400mg/10mL (40mg/mL).*

FDA Label Image

Serialized Label (Serialized 51662 1291 1 Dopamine 5ml Vial)

FDA Label Image

Precautions 1 (Untitled)

The text describes a procedure to prevent tissue damage in ischemic areas by infiltrating the area with a saline solution containing phentolamine mesylate, an adrenergic blocking agent. This should be done within 12 hours of noticing the issue, and doing so causes immediate hyperemic changes. The text emphasizes the importance of administering phentolamine as soon as possible.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.